ASCIA online courses provide accessible, consistent and evidence-based training in anaphylaxis, allergy and immune deficiencies. The updated 2025 version of ASCIA anaphylaxis e-training for health professionals has been approved as a CPD activity by the following professional organisations:

• Royal Australian College of General Practitioners (RACGP)
• Australian College of Rural and Remote Medicine (ACRRM)
• Pharmaceutical Society of Australia (PSA) 

ASCIA Online Training Updates 2025

To enhance the user experience, improve access and increase usage, in 2025 ASCIA etraining courses have been:

• Improved by including more videos and infographics, in response to feedback from 2023 evaluation surveys
• Updated to include 2025 versions of ASCIA Action Plans for Anaphylaxis
• Moved to new, more user-friendly websites https://traininghp.ascia.org.au/ and https://training.ascia.org.au/

It is important that ASCIA e-training courses are regularly reviewed and updated, as the usage continues to increase since they were first introduced in 2010. 

ASCIA Online Training Completions 

ASCIA anaphylaxis and allergy e-training courses were completed by a total of 124,227 course participants in 2024, a 32% increase compared with 94,193 in 2023, including:

• 87,580 school anaphylaxis course completions - an increase of 19% compared to 74,201 course completions in 2023*
• 14,318 children's education/care (CEC) anaphylaxis course completions - an increase of 57% compared to 9,133 course completions in 2023
• 14,011 health professional anaphylaxis and allergy course completions - an increase of 150% compared to 5,589 course completions in 2023**
• 4,621 schools, CEC and community anaphylaxis refresher course completions - an increase of 30% compared to 3,568 course completions in 2023 
• 2,816 first aid (community) anaphylaxis course completions - an increase of 12% compared to 2,514 course completions in 2023 

*Course completions in 2024 are in addition to completions of ASCIA anaphylaxis e-training courses licenced to be on NSW, QLD and WA Education Departments for use on their LMS platforms. 

**The significant increase in course completions is largely due to the increased promotion of the courses by ASCIA. The increase suggests that there is a high need for health professionals to have access to this form of training, reflecting the rising prevalence of allergic disease in Australia and New Zealand. 

The mandatory evaluation reports for 2024 indicate that ASCIA anaphylaxis and allergy courses for health professionals were completed by:

• 5,622 nurses (including nurse practitioners and nurse assistants)
• 3,132 pharmacists
• 543 pharmacy assistants
• 259 general practitioners
• 108 dietitians
• 97 paediatricians
• 95 medical/health educators
• 81 paramedics
• 3,278 other health professionals

In 2024, ASCIA courses were also completed by 796 students who are not yet working as health professionals. 

Each ASCIA e-training course includes mandatory evaluation surveys which provide feedback about preference regarding online training. Future ASCIA course updates will be based on this feedback, which includes information relevant to undergraduate and postgraduate anaphylaxis and allergy training.

This news item was issued on 10 January and updated on 5 March 2025 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.